(Q46874161)

26 December 2017

title

Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody (English)

1 reference

26 December 2017

1 reference

Michael S Ominsky

1

1 reference

26 December 2017

Qing-Tian Niu

2

1 reference

26 December 2017

Chaoyang Li

3

1 reference

26 December 2017

Xiaodong Li

4

1 reference

26 December 2017

Hua Zhu Ke

5

1 reference

26 December 2017

publication date

1 June 2014

1 reference

26 December 2017

Journal of Bone and Mineral Research

published in

1 reference

26 December 2017

volume

29

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

1424-1430

1 reference

26 December 2017

Bone "mass" and the "mechanostat": a proposal.

cites work

1 reference

Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium

21 January 2018

1 reference

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

21 January 2018

1 reference

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

21 January 2018

1 reference

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

21 January 2018

1 reference

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

21 January 2018

1 reference

Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain

21 January 2018

1 reference

A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide

21 January 2018

1 reference

Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases

21 January 2018

1 reference

Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin

21 January 2018

1 reference

Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.

21 January 2018

1 reference

Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts

21 January 2018

1 reference

Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts

21 January 2018

1 reference

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.2152

1 reference

26 December 2017

PubMed ID

24967455

1 reference

26 December 2017